Work Attendance Despite Headache and Its Economic Impact: A Comparison Between Two Workplaces

Raak, Ragnhild; Raak, Anders

doi:10.1046/j.1526-4610.2003.03212.x

Cited by 18 publications

(24 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Headache is important because work loss, interference with work when present, and impact on activities of daily living have important economic consequences [42,62,72,73]. In this circumstance, it would be reasonable to expect a greater degree of research interest in early-onset analgesics producing faster and better pain relief.…”

Section: Discussionmentioning

confidence: 99%

Evidence for efficacy of acute treatment of episodic tension-type headache: Methodological critique of randomised trials for oral treatments

Moore

Derry

Wiffen

et al. 2014

Pain

View full text Add to dashboard Cite

The International Headache Society (IHS) provides guidance on the conduct of trials for acute treatment of episodic tension-type headache (TTH), a common disorder with considerable disability. Electronic and other searches identified randomised, double-blind trials of oral drugs treating episodic TTH with moderate or severe pain at baseline, or that tested drugs at first pain onset. The aims were to review methods, quality, and outcomes reported (in particular the IHS-recommended primary efficacy parameter pain-free after 2 hours), and to assess efficacy by meta-analysis. We identified 58 reports: 55 from previous reviews and searches, 2 unpublished reports, and 1 clinical trial report with results. We included 40 reports of 55 randomised trials involving 12,143 patients. Reporting quality was generally good, with potential risk of bias from incomplete outcome reporting and small size; the 23 largest trials involved 82% of patients. Few trials reported IHS outcomes. The number needed to treat values for being pain-free at 2 hours compared with placebo were 8.7 (95% confidence interval [CI] 6.2 to 15) for paracetamol 1000 mg, 8.9 (95% CI 5.9 to 18) for ibuprofen 400mg, and 9.8 (95% CI 5.1 to 146) for ketoprofen 25mg. Lower (better) number needed to treat values were calculated for outcomes of mild or no pain at 2 hours, and patient global assessment. These were similar to values for these drugs in migraine. No other drugs had evaluable results for these patient-centred outcomes. There was no evidence that any one outcome was better than others. The evidence available for treatment efficacy is small in comparison to the size of the clinical problem.

show abstract

Section: Discussionmentioning

confidence: 99%

Evidence for efficacy of acute treatment of episodic tension-type headache: Methodological critique of randomised trials for oral treatments

Moore

Derry

Wiffen

et al. 2014

Pain

View full text Add to dashboard Cite

show abstract

“…Because prevalence of migraine peaks during the most productive years of life, between ages of 25 and 55, it is an important cause of lost work time. Indirect costs account for more than 80% of economic burden [27,28]. We estimated the economic consequences of productivity loss ( indirect costs) related to headache in the university hospital to 14 million CHF (9.5 million EUR), representing 3.2% of the overall annual personnel expenditure.…”

Section: Discussionmentioning

confidence: 99%

Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact

Sokolovic¹,

Riederer

Szucs

et al. 2013

J Headache Pain

View full text Add to dashboard Cite

BackgroundThe objectives of this cross-sectional, observational study were to determine the prevalence of self-reported headache among the employees of the large Swiss university hospital, to measure the impact of headache using the MIDAS questionnaire, to assess current treatment and to estimate economic burden of headache considering indirect costs.MethodsA self-administered questionnaire was distributed internally to 2000 randomly selected employees of the University Hospital Zurich.Results1210 employees (60.5%) responded. Of the 1192 (98.5%) employees who provided sufficiently complete information, 723 (61%) reported at least one headache type in the last three months. The prevalence of migraine, and tension-type headache was 20% and 50%, respectively. Regarding the occupational groups, there was a trend that healthcare staff, administration employees, and medical technicians suffered more from headaches than physicians, correcting for age and sex. The economic consequences of lost productivity were calculated to amount to approximately 14 million Swiss Francs (9.5 million EUR), representing 3.2% of the overall annual expenditure of the hospital for personnel.ConclusionHeadache is highly prevalent among university hospital employees, with significant economic impact.

show abstract

“…The great difference between lost and inefficient work/school days supports this suggestion. In a study on Swedish patients the ratio of going to work despite headache among patients with headache was 50% [23].…”

Section: Discussionmentioning

confidence: 97%

Economic impact of primary headaches in Turkey: a university hospital based study: part II

et al. 2006

View full text Add to dashboard Cite

This study was planned to investigate the economic impact of headache on Turkish headache sufferers attending a tertiary care outpatient headache clinic. A total of 937 headache patients were included in this study and questioned using a questionnaire for the profile of patients and headache, quality of life of patients and economic impact of headache. The median total direct cost was found to be 88.0 USD and the median total cost was 160.7 USD. The drug treatment cost was the highest item followed by the specialist outpatient care cost. The average lost and inefficient work/school days was 1.5 (0-45) and 8.4 (0-100) days for one year. It was shown that loss of productivity was higher for migraine without aura group when compared with the episodic and chronic tension-type headache groups. The results of this nationwide university hospital based study

show abstract

Work Attendance Despite Headache and Its Economic Impact: A Comparison Between Two Workplaces

Abstract: The economic burden of headache experienced at work is substantial, suggesting that workplace-based treatment and prevention programs emphasizing stress management may be financially, as well as clinically, advantageous.

Cited by 18 publications

References 15 publications

Evidence for efficacy of acute treatment of episodic tension-type headache: Methodological critique of randomised trials for oral treatments

Evidence for efficacy of acute treatment of episodic tension-type headache: Methodological critique of randomised trials for oral treatments

Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact

Economic impact of primary headaches in Turkey: a university hospital based study: part II

Contact Info

Product

Resources

About